PROCUREMENT INFORMTION BULLETIN NO. 14.069
DATE: June 9, 2014
ITEM: MOBILE X-RAY (DIGITAL RADIOGRAPHY) UNITS (QTY: 2)
DESCRIPTION: These mobile X-ray/Digital Radiography units to be used for patients that are immobile or patients that are in the intensive care unit or operating room.
ITEM: ULTRASOUND UNIT – Sophisticated Version (QTY: 1)
DESCRIPTION: Ultrasound unit to be used for most examinations for clinical and research purposes. Unit should be a premium high-resolution system equipped with six (6) transducers.
ITEM: ULTRASOUND UNIT – Standard Version (QTY: 2)
DESCRIPTION: Ultrasound unit to be used in radiology department and other departments as needed including ICUs. Unit should be mid-range and mobile system. Unit should be high-resolution with four (4) transducers.
AUTHORITY: USAID Award Number AID-ASHA-G-13-00022
US AUTHORIZED
GEOGRAPHIC CODE: 937
COUNTRY: Israel
PURCHASING AGENT
OR ENTITY: SHAARE ZEDEK MEDICAL CENTER
P.O. Box 3235
91031 JERUSALEM, ISRAEL
NOTE: The SHAARE ZEDEK MEDICAL CENTER requests bids for the above described commodity. To obtain a copy of the solicitation including the terms and specifications, please send a request to the SHAARE ZEDEK MEDICAL CENTER in Israel at:
1. Fax No. 972-2-6513946, clearly stating a fax number that can be reached 24 hours a day,
2. E-Mail: suter@szmc.org.il
3. A copy can also be obtained from Ms. Bella Klein at the AMERICAN COMMITTEE FOR SHAARE ZEDEK, New York, NY, USA, Tel. No. (212) 764-8045, Fax (212) 398-9724,
E-Mail: bklein@acsz.org.
Please specify the equipment requested. Upon receipt of your request, a copy of the solicitation will be sent to you.
The DEADLINE FOR SUBMISSION OF QUOTES is the close of business on July 28, 2014.
All manufacturer warranties on proposed equipment must be honored in Israel. The quotation must contain the name of a reliable Israeli agent that will carry out the terms of the warranty and who can be used for installation (if needed), spare parts and other services.
Offers are to be in compliance with USAID source and nationality requirements enumerated in 22CFR, part 228.
In order for a quote to be responsive to this notice, suppliers are required to provide a copy of the applicable approval letter from FDA, covering medical devices that require pre-market in the USA.
Additionally, the supplier shall provide the following certification: “The undersigned supplier agrees and certifies that all products provided are covered by a valid FDA approval letter and/or otherwise are in compliance on the date of shipment with all applicable United States of America laws and regulations governing the delivery of regulated products in interstate commerce”